Datamonitor's ImClone Systems Incorporated - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
ImClone Systems is a biopharmaceutical company specializing in the development of therapeutic products for the treatment of cancer and cancer-related disorders, as well as diagnostic products and vaccines for a number of infectious diseases. The company currently markets Erbitux which was approved in its first indication, metastatic colorectal cancer, in 2004. The product is also indicated for the treatment of head and neck squamous cell carcinoma which was approved by the FDA in March 2006. ImClone Systems is headquartered in New York City, New York and employed 1,128 people as of January 2008. The company recorded revenues of $591 million during the financial year (FY) ended December 2007, a decrease of 12.8% over FY2006. The decrease was primarily attributable to fewer license and milestone revenues received from its partner, Bristol-Myers Squibb, alongside lower manufacturing revenues related to efficiencies in the manufacturing of Erbitux during the year. The operating income of the company was $51 million during FY2007, as compared to an operating income of $289 million in FY2006. The net profit was $40 million in FY2007, as compared to a net profit of $371 million in FY2006.
Scope of the Report- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
0 items
